Balance Sheets (USD $)	Apr. 30, 2014	Jul. 31, 2013
Current assets
Cash and cash equivalents	$ 180,827	$ 598,623
Prepaid insurance	41,650	21,250
Total current assets	222,477	619,873
Other assets
Patents and patent applications (net of accumulated amortization of $5,224 at April 30, 2014 and $4,270 at July 31, 2013)	22,226	23,180
Total assets	244,703	643,053
Current liabilities
Accounts payable and accrued liabilities	19,060	40,767
Accrued salaries and wages	1,131,893	457,636
Due to related party	350,000	350,000
Convertible notes payable, net of debt discounts		25,000
Derivative liability		9,666
Total current liabilities	1,500,953	883,069
Deferred revenue	1,003,500	750,000
Total liabilities	2,504,453	1,633,069
Stockholders' deficit
Common stock; par value $0.001; 200,000,000 shares authorized; 178,207,278 shares issued and outstanding at April 30, 2014 and 164,699,973 shares issued and outstanding at July 31, 2013	178,206	164,700
Additional paid-in capital	39,735,580	33,695,679
Accumulated deficit during the development stage	(42,173,536)	(34,850,395)
Total stockholders' deficit	(2,259,750)	(990,016)
Total liabilities and stockholders' deficit	$ 244,703	$ 643,053